Miami Miller School Of Medicine
Smoking associated with mutations linked to myelodysplastic syndrome
SAN DIEGO — Genetic mutations related to myelodysplastic syndrome occurred significantly more often among people who smoked than nonsmokers, according to study results presented at ASH Annual Meeting and Exposition.
Intraosseous vancomycin may reduce PJI risk in revision TKA
DALLAS — Data presented at the American Association of Hip and Knee Surgeons Annual Meeting showed use of intraosseous vancomycin infusion may reduce periprosthetic joint infection vs. IV vancomycin in revision total knee arthroplasty.
Bereavement care, often an ‘afterthought,’ should be public health priority
Health care institutions and their staffs must take action to ensure bereavement care shifts from “an afterthought to a public health priority,” according to a position paper published in The Lancet Public Health.
Liraglutide plus risk factor modification improves freedom from AF after ablation: LEAF
PHILADELPHIA — Adults with obesity and atrial fibrillation treated with liraglutide plus risk factor modification had improved outcomes after catheter ablation compared with those prescribed risk factor modification alone.
FDA approves Vanflyta for newly diagnosed acute myeloid leukemia
The FDA approved quizartinib for use in combination with standard chemotherapy for treatment of patients with newly diagnosed acute myeloid leukemia with FLT3 internal tandem duplication mutations.
Cancers with high incidence among racial/ethnic minorities receive less research funding
Federal research funding appeared to be allocated more toward cancer types with higher incidence among white people than members of other racial and ethnic groups, according to a study published in Journal of the National Cancer Institute.
Unmet supportive care needs linked to worse outcomes among ambulatory patients with cancer
Unmet supportive care needs appeared associated with worse clinical outcomes among a cohort of ambulatory patients with cancer, according to study results published in JAMA Network Open.
Strategy may enable some patients with HER2-positive breast cancer to avoid chemotherapy
CHICAGO — A chemotherapy de-escalation strategy involving dual HER2 blockade resulted in high rates of 3-year invasive DFS among patients with HER2-positive early breast cancer, according to study results presented at ASCO Annual Meeting.
Neoadjuvant FOLFIRINOX fails to extend survival in resectable pancreatic cancer
CHICAGO — Neoadjuvant FOLFIRINOX chemotherapy failed to extend OS compared with upfront surgery for patients with resectable pancreatic head cancer, according to study results presented at ASCO Annual Meeting.
Dobbs decision could worsen physician shortages in some states
The Dobbs v. Jackson Women’s Health Initiative decision in June 2022 had, and continues to have, broad implications for reproductive health rights nationwide.